ArticleCellular oncology (Dordrecht, Netherlands)2021

Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.

Ioannis Pozios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.